Pfizer Inc. announced on Friday that the FDA has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January. … A full approval for the Pfizer vaccine could help boost U.S. vaccination efforts. Some people who have been reluctant to get a shot have said they are unwilling to get an experimental medication, and an approval could also make it easier for employers, school districts and others to mandate vaccination, Bloomberg News reported.